On 10 September, Swiss 3PL Kuehne + Nagel (K+N) announced that “with the opening of airside pharma & healthcare hubs in Brussels, Belgium, and Johannesburg, South Africa,” it “adds two strategic elements to its global GxP-certified network of temperature-controlled facilities for the distribution of vaccines and other pharma & healthcare products.”

This in a world where vaccine prototypes may or may not work and where air is tight and ...

Subscription required for Premium stories

In order to view the entire article please login with a valid subscription below or register an account and subscribe to Premium

Or buy full access to this story only for £13.00

Please login to activate the purchase link or sign up here to register an account

Premium subscriber
New Premium subscriber REGISTER

Comment on this article

You must be logged in to post a comment.